论文部分内容阅读
辉瑞制约公司于2004年9月27日在北京宣布,根据中国国家药品监督管理局和卫生部联合颁发的国食药龄市(2004)358号文件,辉瑞公司生产的万艾可已获准作为唯一治疗男性勃起性功能障碍(ED)的药物,在药品零售企业进行销售,患者凭医生处方,即可在北京、上海和广州等全国各主要城市的各大零售药店购买到万艾可,同时,万艾可的处方权限也进一步得到开放、辉瑞制药有限公司生产的万艾可处方,可由二级以上综合医院和心血管、男性病及精神病专科医院的泌尿外科、男性科、心血管内科、内分泌科、神经内科、精神科和老年科具有住院医师以上专业技术职务任职资格,并经执业注册的医师开具。
Pfizer Inc. announced on September 27, 2004 in Beijing that Pfizer’s Viagra has been approved as the only treatment for men based on the Guofan Pharmaceutical Age (2004) No. 358 document jointly issued by China’s State Drug Administration and the Ministry of Health. Erectile Dysfunction (ED) drugs are marketed at drug retailers and prescriptions are available to patients at major retail pharmacies in major cities across the country, including Beijing, Shanghai and Guangzhou. At the same time, Viagra’s prescription rights It is also further open to Viagra’s Pfizer Pharmacopoeia prescription, which can be prescribed by urology, men’s, cardiology, endocrinology, neurology, psychiatry and psychiatry in general hospitals and cardiovascular, men’s and psychiatric hospitals at level 2 and above Geriatrics with residency above professional and technical positions qualifications, and registered practitioners issued a doctor.